Identification of novel pharmacological activities of an antifungal agent, nystatin, to promote dendritic cell maturation

Abstract

As an unbiased functional screen to identify agents activating dendritic cells (DCs), we recently developed a DC-based biosensor system, in which a stable murine DC line XS106 was engineered to express the yellow fluorescent protein (YFP) gene under the control of the IL-1β promoter. Here we report that nystatin (NYT), an antifungal drug of the family of polyene macrolide antibiotics, elevated YFP expression by the resulting XS106-pIL1-YFP DC biosensor clone in a dose-dependent fashion. With respect to the underlying mechanisms, NYT activated the NFκB p65 and c-Rel subunits in the parental XS106 DC line. Moreover, NYT dose-dependently increased the surface expression of major histocompatibility complex (MHC) class II (MHC II), CD40, CD54, CD80, and CD86 by murine bone marrow-derived DCs and triggered their robust production of IL-1β, IL-6, IL-12, tumor necrosis factor α, and macrophage inflammatory protein-1α. Our results document previously unrecognized pharmacological activities of the most commonly used antifungal drug to promote DC maturation. © 2005 The Society for Investigative Dermatology.